Sponsor Deadline
Posted: 9/1/2022

Afdhal / McHutchison LIFER Award

The purpose of this two-year, $100,000 ($50,000/year) award is to foster career development for fellows performing clinical research and/or translational research in a liver-related area and who have shown commitment to excellence at an early stage of their research study. The award is intended to ensure that a significant portion of the investigators’ time is protected for research, with an overall objective of enabling the investigators to develop independent and productive research careers in liver disease.

International applicants who have been accepted into a fellowship position at a North American institution are strongly encouraged to apply.

Application Deadline:  December 5, 2022

Eligibility Requirements
  • Applicant must be a postdoctoral or clinical research fellow who has completed their most recent doctoral degree or medical residency within the past five (5) years at the start of the grant term (July 1, 2020).
  • Applicants from North America must be working at an academic, medical, or research institution at the time of application and for the duration of the award.
  • Applicants from outside of North America must have already been accepted into a fellowship position at a North American education institution at the time of application and for the duration of the award. Positions contingent on receipt of the award are also acceptable. The North American fellowship position must start no later than the award start date (July 1, 2020) and end no earlier than the award end date (June 30, 2022). International applicants must have a student or trainee Visa to the country where the fellowship will occur.
  • The applicant must be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
  • The applicant must have a mentor at the North American institution who is an AASLD member in good standing for the duration of the award.
  • Project is clinical or translational. “Clinical Research” is defined as studies related to patients or disease processes having direct contact between the principal investigator and humans. Clinical research includes epidemiology and clinical trials in liver disease. “Translational Research” is defined as clinical research with a substantial component of laboratory investigation using blood or tissue specimens from patients with liver disease.
  • Funded projects must be completed at the North American institution.
  • At least 80 percent effort should be devoted to research activities related to the award.
  • Applicant does not hold other similar research awards.
  • Applicant may only apply for one (1) AASLD Foundation (AASLDF) award per application cycle.